Document is current
Any future updates will be listed below
-
Authors
Mole, Damian J. http://orcid.org/0000-0001-6884-7302
Fallowfield, Jonathan A.
Kendall, Timothy J.
Welsh, Fenella
Semple, Scott I.
Bachtiar, Velicia
Kelly, Matt
Wigmore, Stephen J.
James Garden, O.
Wilman, Henry R.
Banerjee, Rajarshi
Rees, Myrddin
Brady, Michael
-
Funding
Funding for this research was provided by:
Innovate UK (102844)
- License Information
-
More Information
Article History
Received: 27 July 2017
Accepted: 9 August 2018
First Online: 12 September 2018
Ethics approval and consent to participate
: This study has been reviewed as IRAS 223180 by the South East Scotland Research Ethics Committee 02, 17/SS/0049 who gave a favourable opinion. NHS Scotland R&D approval and NHS England HRA approval have been granted. The study sponsor is University of Edinburgh/NHS Lothian ACCORD. This study is registered on ClinicalTrials.gov Identifier: NCT03213314.All individuals recruited to the study participated freely and after fully-informed consent.
: All authors have approved the submission of this manuscript for publication. No restriction of future publication of data is made by any of the study partners.
: The University of Edinburgh members declare no conflict of interest with this study. Similarly, employees of Basingstoke and North Hampshire Hospital declare no conflict of interest. Perspectum Diagnostics Ltd. is a privately-funded small commercial enterprise that develops MRI-based medical devices to address unmet clinical needs, including Liver<i>MultiScan™</i>. As the industrial partner in this study, it has a commercial interest in the outcome.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
